Pascal Bonnabry
Pascal Bonnabry
Geneva University Hospitals
Verified email at - Homepage
Cited by
Cited by
Analysis of anticancer drugs: a review
S Nussbaumer, P Bonnabry, JL Veuthey, S Fleury-Souverain
Talanta 85 (5), 2265-2289, 2011
Successful implementation of the World Health Organization hand hygiene improvement strategy in a referral hospital in Mali, Africa
B Allegranzi, H Sax, L Bengaly, H Riebet, DK Minta, MN Chraiti, ...
Infection Control & Hospital Epidemiology 31 (2), 133-141, 2010
Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile
N Vernaz, H Sax, D Pittet, P Bonnabry, J Schrenzel, S Harbarth
Journal of Antimicrobial Chemotherapy 62 (3), 601-607, 2008
Use of a systematic risk analysis method to improve safety in the production of paediatric parenteral nutrition solutions
P Bonnabry, L Cingria, F Sadeghipour, H Ing, C Fonzo-Christe, RE Pfister
BMJ Quality & Safety 14 (2), 93-98, 2005
A risk analysis method to evaluate the impact of a computerized provider order entry system on patient safety
P Bonnabry, C Despont-Gros, D Grauser, P Casez, M Despond, D Pugin, ...
Journal of the American Medical Informatics Association 15 (4), 453-460, 2008
Use of a prospective risk analysis method to improve the safety of the cancer chemotherapy process
P Bonnabry, L Cingria, M Ackermann, F Sadeghipour, L Bigler, N Mach
International Journal for Quality in Health Care 18 (1), 9-16, 2006
A major role for cytochrome P450TB (CYP2C subfamily) in the actions of non-steroidal antiinflammatory drugs.
TD Leemann, C Transon, P Bonnabry, P Dayer
Drugs under experimental and clinical research 19 (5), 189-195, 1993
Use of transdermal drug formulations in the elderly
LZ Kaestli, AF Wasilewski-Rasca, P Bonnabry, N Vogt-Ferrier
Drugs & aging 25, 269-280, 2008
Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding community
N Vernaz, B Huttner, D Muscionico, JL Salomon, P Bonnabry, ...
Journal of Antimicrobial Chemotherapy 66 (4), 928-935, 2011
Subcutaneous administration of drugs in the elderly: survey of practice and systematic literature review
C Fonzo-Christe, C Vukasovic, AF Wasilewski-Rasca, P Bonnabry
Palliative medicine 19 (3), 208-219, 2005
Microbial contamination of syringes during preparation: the direct influence of environmental cleanliness and risk manipulations on end-product quality
C StuCki, AAMAA SAutter, JC FAvet, P BonnABry
American Journal of Health-System Pharmacy 66 (22), 2032-2036, 2009
Reliable low-cost capillary electrophoresis device for drug quality control and counterfeit medicines
RD Marini, E Rozet, MLA Montes, C Rohrbasser, S Roht, D Rhème, ...
Journal of Pharmaceutical and Biomedical Analysis 53 (5), 1278-1287, 2010
Drug-related problems identification in general internal medicine: the impact and role of the clinical pharmacist and pharmacologist
B Guignard, P Bonnabry, A Perrier, P Dayer, J Desmeules, CF Samer
European journal of internal medicine 26 (6), 399-406, 2015
Role of human liver microsomal CYP2C9 in the biotransformation of lornoxicam
P Bonnabry, T Leemann, P Dayer
European journal of clinical pharmacology 49, 305-308, 1996
Patented drug extension strategies on healthcare spending: a cost-evaluation analysis
N Vernaz, G Haller, F Girardin, B Huttner, C Combescure, P Dayer, ...
PLoS medicine 10 (6), e1001460, 2013
Wipe sampling procedure coupled to LC–MS/MS analysis for the simultaneous determination of 10 cytotoxic drugs on different surfaces
S Nussbaumer, L Geiser, F Sadeghipour, D Hochstrasser, P Bonnabry, ...
Analytical and bioanalytical chemistry 402, 2499-2509, 2012
Compatibility of intravenous medications with parenteral nutrition: in vitro evaluation
L Bouchoud, C Fonzo‐Christe, M Klingmüller, P Bonnabry
Journal of Parenteral and Enteral Nutrition 37 (3), 416-424, 2013
Effectiveness of a closed-system transfer device in reducing surface contamination in a new antineoplastic drug-compounding unit: a prospective, controlled, parallel study
N Simon, M Vasseur, M Pinturaud, M Soichot, C Richeval, L Humbert, ...
PLoS One 11 (7), e0159052, 2016
Antineoplastic drugs and their analysis: a state of the art review
N Guichard, D Guillarme, P Bonnabry, S Fleury-Souverain
Analyst 142 (13), 2273-2321, 2017
Measuring human-error probabilities in drug preparation: a pilot simulation study
P Garnerin, B Pellet-Meier, P Chopard, T Perneger, P Bonnabry
European journal of clinical pharmacology 63, 769-776, 2007
The system can't perform the operation now. Try again later.
Articles 1–20